Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

BACKGROUND: Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. OBJECTIVES: The objective of the RIETECAT study was to compare the long‐term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondar...

Descripción completa

Detalles Bibliográficos
Autores principales: Trujillo‐Santos, Javier, Farge‐Bancel, Dominique, Pedrajas, José María, Gómez‐Cuervo, Covadonga, Ballaz, Aitor, Braester, Andrei, Mahé, Isabelle, Villalobos, Aurora, Porras, José Antonio, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164243/
https://www.ncbi.nlm.nih.gov/pubmed/35664535
http://dx.doi.org/10.1002/rth2.12736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164243/
https://www.ncbi.nlm.nih.gov/pubmed/35664535
http://dx.doi.org/10.1002/rth2.12736

Ejemplares similares